Combination targeted therapy provides durable remission for patients with CLL

Combination targeted therapy provides durable remission for patients with CLL

A combination of ibrutinib and venetoclax was found to provide lasting disease remission in patients...
read more
Immunotherapy—targeted drug combination improves survival in advanced kidney cancer

Immunotherapy—targeted drug combination improves survival in advanced kidney cancer

Patients with advanced kidney cancer, who received...
read more
Amputations of body parts: The combination of diabetes and gout causes significant increases in risk

Amputations of body parts: The combination of diabetes and gout causes significant increases in risk

Diabetes mellitus and gout are ranked among the mo...
read more
Little-used drug combination may extend the lives of lung transplant patients

Little-used drug combination may extend the lives of lung transplant patients

Lung transplantation can prolong the lives of pati...
read more
Physical combination multiplies melanoma risk

Physical combination multiplies melanoma risk

The risk of developing melanoma is significantly m...
read more